Crack – da pedra ao tratamento



Baixar 93,04 Kb.
Página9/9
Encontro17.10.2018
Tamanho93,04 Kb.
1   2   3   4   5   6   7   8   9
Referências
1. Ribeiro M, dunn J, Sesso R, Dias AC, Laranjeira R. Causes of death among crack cocaine users. Rev Bras Psiquiatr 2006;28(3):196-202.

2. Ribeiro M, Dunn J, Laranjeira R, Sesso R. High mortality among young crack cocaine users in Brazil: a 5-year follw-up study. Addiction 2004;99:1133-1135.

3. Oliveira LG, Nappo SA. Caracterização da cultura de crack na cidade de São Paulo: padrão de uso controlado. Rev Saúde Pública 2008;42(4):64-671.

4. Dualibi LB, Ribeiro M, Laranjeira R. Profile of cocaine and crack users in

Brazil. Cad. Saúde Pública 2008;24[ suppl.4]:545-57.

5. Goldstein RA, DesLauriers C, Burda AM. Cocaine: History, Social Implications, and Toxicity – A Review. Dis Mon 2009;55:6-38.

6. Schifano F, Corkery J. Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990-2004). Journal of Psychopharmacology 2008;22(1):71-79.

7. Falck RS, Wang J, Carlson RG, Siegel HA. Crack-Cocaine Use and Health Status as Defined by the SF-36. Addictive Behaviors 2000;2():579-84.

8. Galduróz JCF, Noto AR, Fonseca AM, Carlini EA. V Levantamento Nacional sobre o consumo de Drogas Psicotrópicas entre Estudantes do Ensino Fundamental e Médio da Rede Pública de Ensino nas 27 Capitais Brasileiras. São Paulo: Centro Brasileiro de Informações sobre Drogas Psicotrópicas – CEBRID/Secretaria Nacional Antidrogas – SENAD, 2004.

9. Carlini EA, Galduróz JCF, Noto AR, Nappo SA. I Levantamento Domiciliar sobre o Uso de Drogas Psicotrópicas no Brasil: Estudo Envolvendo as 107 Maiores Cidades do País. Centro Brasileiro de Informações sobre Drogas Psicotrópicas – CEBRID/Secretaria Nacional Antidrogas – SENAD, 2001.

10. Carlini EA, Galduróz JCF, Noto AR, Fonseca AM, Carlini CM, Oliveira LG, Nappo AS, Moura YG, Sanchez Z van der M. II Levantamento Domiciliar sobre o Uso de Drogas Psicotrópicas no Brasil: Estudo envolvendo as 108 maiores cidades do país – 2005. Centro Brasileiro de Informações sobre Drogas Psicotrópicas – CEBRID/Secretaria Nacional Antidrogas – SENAD, 2006.

11. Wagner GA, Andrade AG de. Uso de álcool, tabaco e outras drogas entre estudantes universitários brasileiros: [revisão]. Rev Psiquiatr Clín 2008; 35(supl.1): 48-54.

12. Ferreira Filho OF, Turchi MD, Laranjeira R, Castelo A. Perfil sociodemográfico e de padrões de uso entre dependentes de cocaína hospitalizados. Rev. Saúde Pública 2003;37(6)751-759.

13. Guimarães CF, Santos DVV, Freitas RC, Araujo RB. Perfil do usuário de crack e fatores relacionados à criminalidade em unidade de internação para desintoxicação no Hospital Psiquiátrico São Pedro de Porto Alegre (RS). Rev Psiquiatr RS 2008;30(2):101-108.

14. Fischer B, Coghlan M. Crack Use in North American cities: the neglected ‘epidemic’. Addiction 2007;102:1340-41.

15. Fischer B, Rehm J, Patra J, Kalousek K, Haydon E, Tyndall M, El-Guebaly N. Crack across Canada: comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 2006;101:1760-1770.

16. Haasen C, Prinzleve M, Zurhold H, Rehm J, Güttinger F, Fischer G, et al. Cocaine Use in Europe – A Multi-Centre Study. Eur Addict Res 2004;10:139-146.

17. Observatório Europeu da Droga e da Toxicodependência. Relatório Anual 2009: a evolução do fenômeno da droga na Europa. Luxemburgo: Serviço das Publicações da União Européia, 2009.

18. Sanchez Z van der M, Nappo AS. Seqüência de drogas consumidas por usuários de crack e fatores interferentes. Rev Saúde Pública 2002;36(4):420-430.

19. Nestler E. Molecular neurobiology of addiction. Am J Addict. 2001;10(3):201-17.

20. Koob G, Sanna P, Bloom F. Neuroscience of addiction. Neuron. 1998;21(3):467-76.

21. Kelley A, Berridge K. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci. 2002;22(9):3306-11.

22. Thomas M, Kalivas P, Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol. 2008;154(2):327-42.

23. Lambert G, Karila L, Lowenstein W. [Neuroimaging and cocaine: mapping dependence?]. Presse Med. 2008;37(4 Pt 2):679-88.

24. Gatley S, Volkow N, Wang G, Fowler J, Logan J, Ding Y, et al. PET imaging in clinical drug abuse research. Curr Pharm Des. 2005;11(25):3203-19.

25. Verdejo-García A, Pérez-García M, Sánchez-Barrera M, Rodriguez-Fernández A, Gómez-Río M. [Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse]. Rev Neurol. 2007;44(7):432-9.

26. Romano M, Ribeiro M, Marques A. Abuso e Dependência da Cocaína (Projeto Diretrizes). Associação Brasileira de Psiquiatria; 2002.

27. Nestler E. The neurobiology of cocaine addiction. Sci Pract Perspect. 2005;3(1):4-10.

28. Kessler F, Pechansky F. Uma visão psiquiátrica sobre o fenômeno do crack na atualidade. Rev Psiquiatr Rio Gd Sul. 2008;30(2):96-98.

29. Knapp WP, Soares B, Farrell M, de Lima SM. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders (Review). Cochrane Database of Systematic Reviews, Issue 1, 2009.

30. Lopez A, Becoña E, Vieitez I, Cancelo J, Sobradelo J, Garcia J, et al. [What happens in a cocaine-dependent sample after 24 months of treatment?]. Adicciones 2008;20(4):347-55.

31. Mcclelland, GT. The effects and management of crack cocaine dependence. Nursing Times 2005;101(29): 26-27.

32. Pinho P, Oliveira M, Almeida M. The psychosocial rehabilitation of individuals with alcohol and drug use disorders: a possible strategy? Rev Psiquiatr Clín. 2008;35(1):82-8.

33. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101(11):1546–1560.

34. Guimarães A, Hochgraf P, Brasiliano S, Ingberman Y. Family aspects of alcohol and drug-dependent in adolescent girls. Rev Psiquiatr Clín. 2009;36(2):69-74.

35. Carmona CGH, Barro RS, Toba JR, Canobr VH, Montequín EA. Family fuction of out-of-treatment cocaine base paste and cocaine hydrochloride users 1: Addict Behav 2008;33(7):866-79.

36. Stanton M, Shadish W. Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol Bull. 1997;122(2):170-91.

37. Kessler F, Woody GE, Boni R, Diemen LV, Benzano D, Faller S, Pechansky F. Evaluation of psychiatric symptoms in cocaine users in the Brazilian public health system: Need for data and structure. Public Health 2008;122:1349-1355.

38. Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S et al. New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol. 2008;11(3):425-38.

39. Preti A. New developments in the pharmacotherapy of cocaine abuse. Addict Biol. 2007;12(2):133-51.61.

40. Moos R. Theory-based active ingredients of effective treatments for substance use disorders. Drug Alcohol Depend. 2007;88(2-3):109-21.

41. William R, James LM, Sorensen JA, Selzer GSB. Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment 2006;31:25– 39.

42. Oliveira LG, Nappo SA. Caracterização da cultura de crack na cidade de São Paulo: padrão de uso controlado. Rev Saúde Pública 2008;42(4):64-671.

43. Galloway AL, Drapela LA. Are Effective Drug Courts an Urban Phenomenon?: Considering Their Impact on Recidivism Among a Nonmetropolitan Adults Sample in Washington State. International Journal of Offender Therapy and Comparative Criminology. 2006; 50:280-293.

44. Wiseman CM. Drug Courts: Framing Policy to Ensure Success. International Journal of Offender Therapy and Comparative Criminology. 2005; 49; 235-238.

45. United States Government Accountability Office. Adult Drug Courts: evidence indicates, recidivism reductions and mixed results for other outcomes. Report to Congressional Committees. 2005.

46. Passey M, Botilho J, Scantleton J, Flaherty B. The Magistrates Early Referral Into Treatment (MERIT) pilot program: court outcomes and recidivism. The Australian and New Zealand Journal of Criminology 2007;40(2):199-217.

47. McIvor G. Therapeutic jurisprudence and procedural justice in Scottish Drug Courts. Criminology and Criminal Justice. 2009; 9(1): 29-49

48. Seddon T. Coerced drug treatment in the criminal justice system: Conceptual, ethical and criminological issues. Criminology and Criminal Justice. 2007; 7(3): 269-286.

49. Weatherburn D, Topp L, Mildord R, Allsopp S. Drug Crime Prevention and Mitigation: A Literature Review and Research Agenda. Sidney: New South Wales Bureau of Crime Statistics and Research, 2000.

50. Freitas CC. Tratamento não voluntário em países da região européia: Princípios éticos, organização e resultados. Disponível em: . Acesso em: 10 de jan. 2008.

51. Siegal HA, Falck RS, Wang J, Carlson RG. Predictors os drug abuse treatment entry among crack-cocaine smokers. Drug and alcohol dependence. 2002;68: 159-166.



52. Dropplemann C. Análisis del proceso de implementación de los Tribunales de Tratamiento de Drogas en Chile. Santiago: Fundación Paz Ciudadana, 2008.

Compartilhe com seus amigos:
1   2   3   4   5   6   7   8   9


©psicod.org 2017
enviar mensagem

    Página principal